Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1

Cited by (1,077)

Items 401–500 of 1,077

1. Fragment-based lead discovery: leads by design
   Robin A. E. Carr, Miles Congreve, Christopher W. Murray, David C. Rees · 2005 · Drug Discovery Today
2. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs
   Arik Dahan, Amnon Hoffman · 2008 · Journal of Controlled Release
3. Small molecules of different origins have distinct distributions of structural complexity that correlate with protein-binding profiles
   Paul A. Clemons, Nicole E. Bodycombe, Hyman A. Carrinski, J. Anthony Wilson, Alykhan F. Shamji, Bridget K. Wagner, Angela N. Koehler, Stuart L. Schreiber · 2010 · Proceedings of the National Academy of Sciences
4. Cancer chemopreventive activity and bioavailability of tea and tea polyphenols
   Joshua D. Lambert, Chung S Yang · 2003 · Mutation research. Fundamental and molecular mechanisms of mutagenesis
5. Lyotropic liquid crystal engineering–ordered nanostructured small molecule amphiphileself-assembly materials by design
   Celesta Fong, Tu C. Le, Calum John Drummond · 2011 · Chemical Society Reviews
6. High throughput physicochemical profiling for drug discovery
   Edward H. Kerns · 2001 · Journal of Pharmaceutical Sciences
7. The Open Access Malaria Box: A Drug Discovery Catalyst for Neglected Diseases
   Thomas Spangenberg, Jeremy Nicholas Burrows, Paul Kowalczyk, Simon McDonald, Timothy N. C. Wells, Paul A. Willis · 2013 · PLoS ONE
8. The significance of acid/base properties in drug discovery
   David T. Manallack, Richard J. Prankerd, Elizabeth Yuriev, Tudor Ionel Oprea, David K. Chalmers · 2012 · Chemical Society Reviews
9. Nucleic acid delivery for therapeutic applications
   Akash Gupta, Jason L. Andresen, Rajith S. Manan, Róbert Langer · 2021 · Advanced Drug Delivery Reviews
10. Fragment-Based Discovery of the Pyrazol-4-yl Urea (AT9283), a Multitargeted Kinase Inhibitor with Potent Aurora Kinase Activity
    Steven Howard, Valério Berdini, John A. Boulstridge, Maria G. Carr, David M. Cross, Jayne E. Curry, Lindsay A. Devine, Theresa R. Early, Lynsey Fazal, Adrian L. Gill et al. · 2008 · Journal of Medicinal Chemistry
11. Intestinal lymphatic drug transport: an update
    Christopher J. H. Porter · 2001 · Advanced Drug Delivery Reviews
12. Natural products and combinatorial chemistry: back to the future
    Jean‐Yves Ortholand, Arasu Ganesan · 2004 · Current Opinion in Chemical Biology
13. High-throughput assays for promiscuous inhibitors
    Brian Y. Feng, Anang A. Shelat, Thompson N. Doman, Rodney Kiplin Guy, Brian K. Shoichet · 2005 · Nature Chemical Biology
14. Degradation of proteins by PROTACs and other strategies
    Wang, Yang, Jiang, Xueyang, Feng, Feng, Liu, Wenyuan, Sun, Haopeng · 2020 · Acta Pharmaceutica Sinica B
15. Lipid-based formulations for oral administration of poorly water-soluble drugs
    Huiling Mu, René Holm, Anette Müllertz · 2013 · International Journal of Pharmaceutics
16. Drug discovery and development for neglected parasitic diseases
    Adam R. Renslo, James Hobson McKerrow · 2006 · Nature Chemical Biology
17. Predicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS)
    Varma, Manthena V., Steyn, Stefanus J., Allerton, Charlotte, El-Kattan, Ayman F. · 2015 · Pharmaceutical Research
18. Understanding and Predicting Druggability. A High-Throughput Method for Detection of Drug Binding Sites
    Peter Schmidtke, Xavier Barril · 2010 · Journal of Medicinal Chemistry
19. Properties of FDA-approved small molecule protein kinase inhibitors: A 2021 update
    Robert Jr. Roskoski · 2021 · Pharmacological Research
20. Rational drug design
    Soma Mandal, Meenal Moudgil, Sanat Kumar Mandal · 2009 · European Journal of Pharmacology
21. The role of mucus on drug transport and its potential to affect therapeutic outcomes
    Xabier Murgia, Brigitta Loretz, Olga Hartwig, Marius Hittinger, Claus‐Michael Lehr · 2017 · Advanced Drug Delivery Reviews
22. The 'rule of three' for fragment-based drug discovery: where are we now?
    Harren Jhoti, Glyn Williams, David C. Rees, Christopher W. Murray · 2013 · Nature Reviews Drug Discovery
23. New agents for the treatment of drug-resistant Mycobacterium tuberculosis
    Daniel T. Hoagland, Jiuyu Liu, Robin B. Lee, Richard E. Lee · 2016 · Advanced Drug Delivery Reviews
24. Binding MOAD (Mother Of All Databases)
    Hu, Liegi, Benson, Mark L., Smith, Richard D., Lerner, Michael G., Carlson, Heather A. · 2005 · Proteins: Structure, Function, and Bioinformatics
25. Antimicrobial Plant Metabolites: Structural Diversity and Mechanism of Action
    Niko S. Radulović, Polina D. Blagojević, Zorica Z. Stojanović-Radić, Nikola M. Stojanović · 2013 · Current Medicinal Chemistry
26. Applications of biological pores in nanomedicine, sensing, and nanoelectronics
    Sheereen Majd, Erik C. Yusko, Yazan N. Billeh, Michael X. Macrae, Jerry Yang, Michael Mayer · 2010 · Current Opinion in Biotechnology
27. A Decade of FDA-Approved Drugs (2010–2019): Trends and Future Directions
    Dean G. Brown, Heike J. Wobst · 2021 · Journal of Medicinal Chemistry
28. High Content Screening Identifies Decaprenyl-Phosphoribose 2′ Epimerase as a Target for Intracellular Antimycobacterial Inhibitors
    Thierry Christophe, Mary Jackson, Hee Kyoung Jeon, Denis Fenistein, Monica Contreras-Domínguez, Jaeseung C. Kim, Auguste Genovesio, Jean‐Philippe Carralot, Fanny Ewann, Eun Hye Kim et al. · 2009 · PLoS Pathogens
29. Relibase: Design and Development of a Database for Comprehensive Analysis of Protein–Ligand Interactions
    Manfred Hendlich, Andreas Bergner, Judith Günther, Gerhard Klebe · 2003 · Journal of Molecular Biology
30. DrugCentral: online drug compendium
    Ursu, Oleg, Holmes, Jayme, Knockel, Jeffrey, Bologa, Cristian G., Yang, Jeremy J., Mathias, Stephen L., Nelson, Stuart J., Oprea, Tudor I. · 2017 · Nucleic Acids Research
31. The endophytic fungus Trametes hirsuta as a novel alternative source of podophyllotoxin and related aryl tetralin lignans
    Satish Chandra Puri, Asiya Nazir, Raman Chawla, Rajesh Arora, Syed Riyaz‐Ul‐Hassan, Touseef Amna, Bilal Ahmed, Vijeshwar Verma, Shikha Singh, Ravinder Sagar et al. · 2005 · Journal of Biotechnology
32. Properties and identification of human protein drug targets
    Tala M. Bakheet, Andrew J. Doig · 2009 · Bioinformatics
33. Penetration of drugs through skin, a complex rate-controlling membrane
    Marie‐Alexandrine Bolzinger, Stéphanie Briançon, Jocelyne Pelletier, Yves Chevalier · 2012 · Current Opinion in Colloid & Interface Science
34. Exploring Chemical Space for Drug Discovery Using the Chemical Universe Database
    Jean‐Louis Reymond, Mahendra Awale · 2012 · ACS Chemical Neuroscience
35. An improved relaxed complex scheme for receptor flexibility in computer-aided drug design
    Rommie E. Amaro, Riccardo Baron, James Andrew McCammon · 2008 · Journal of Computer-Aided Molecular Design
36. Bioavailability and bioaccessibility of food bioactive compounds; overview and assessment by in vitro methods
    Cristian Vasile Dima, Elham Assadpour, Ştefan Dima, Seid Mahdi Jafari · 2020 · Comprehensive Reviews in Food Science and Food Safety
37. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors
    Sabrina Dallavalle, Vladimir Dobričić, Loretta Lazzarato, Elena Gazzano, Miguel Machuqueiro, Ilza K. Pajeva, Ivanka Tsakovska, Nace Zidar, Roberta Fruttero · 2020 · Drug Resistance Updates
38. Current methodologies used for evaluation of intestinal permeability and absorption
    Praveen V. Balimane, Saeho Chong, Richard A. Morrison · 2000 · Journal of Pharmacological and Toxicological Methods
39. Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticity
    Robert J. Young, Darren V. S. Green, Christopher N. Luscombe, Alan P. Hill · 2011 · Drug Discovery Today
40. Drug Discovery Using Chemical Systems Biology: Repositioning the Safe Medicine Comtan to Treat Multi-Drug and Extensively Drug Resistant Tuberculosis
    Sarah Kinnings, Nina Liu, Nancy A. Buchmeier, Peter J. Tonge, Lei Xie, Philip E. Bourne · 2009 · PLoS Computational Biology
41. Epigallocatechin-3-Gallate Is Absorbed but Extensively Glucuronidated Following Oral Administration to Mice
    Joshua D. Lambert, Mao‐Jung Lee, Hong Lu, Xiaofeng Meng, Jihyeung Ju Jungil Hong, Darren N. Seril, Chung Shu Yang, Marc G. Sturgill · 2003 · Journal of Nutrition
42. Polysaccharide based nanogels in the drug delivery system: Application as the carrier of pharmaceutical agents
    Tilahun Ayane Debele, Shewaye Lakew Mekuria, Hsieh‐Chih Tsai · 2016 · Materials Science and Engineering C
43. Molecular Shape and Medicinal Chemistry: A Perspective
    Anthony O. Nicholls, Georgia B. McGaughey, Robert P. Sheridan, Andrew C. Good, Gregory L. Warren, Magali Mathieu, Steven W. Muchmore, Scott P. Brown, Jennifer Grant, James A. Haigh et al. · 2010 · Journal of Medicinal Chemistry
44. Tailored Approaches in Drug Development and Diagnostics: From Molecular Design to Biological Model Systems
    Cecilia Sahlgren, Annika Meinander, Hongbo Zhang, Fang Cheng, Maren Preis, Chunlin Xu, Tiina Annamaria Salminen, Diana M. Toivola, Daniel Abankwa, Ari Rosling et al. · 2017 · Advanced Healthcare Materials
45. Properties of FDA-approved small molecule protein kinase inhibitors: A 2023 update
    Robert Jr. Roskoski · 2022 · Pharmacological Research
46. A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells
    Andrew J. Massey, Douglas S. Williamson, Helen L. Browne, James B. Murray, Pawel Dokurno, Terry Shaw, Alba T. Macias, Zoe Daniels, Stephanie Geoffroy, Melanie Dopson et al. · 2009 · Cancer Chemotherapy and Pharmacology
47. Aerogels in drug delivery: From design to application
    Carlos A. García‐González, Alejandro Sosnik, József Kalmár, Iolanda De Marco, Can Erkey, Ángel Concheiro, Carmen Alvarez‐Lorenzo · 2021 · Journal of Controlled Release
48. Utilizing graph machine learning within drug discovery and development
    Gaudelet, Thomas, Day, Ben, Jamasb, Arian R, Soman, Jyothish, Regep, Cristian, Liu, Gertrude, Hayter, Jeremy B R, Vickers, Richard, Roberts, Charles, Tang, Jian et al. · 2021 · Briefings in Bioinformatics
49. The future of molecular dynamics simulations in drug discovery
    Borhani, David W., Shaw, David E. · 2012 · Journal of Computer-Aided Molecular Design
50. To Gibberellins and Beyond! Surveying the Evolution of (Di)Terpenoid Metabolism
    Jiachen Zi, Sibongile Mafu, Reuben J. Peters · 2014 · Annual Review of Plant Biology
51. Preparation and Characterization of Nanofibers Containing Amorphous Drug Dispersions Generated by Electrostatic Spinning
    Geert Verreck, Iksoo Chun, Jef Peeters, Joel Rosenblatt, Marcus Eli Brewster · 2003 · Pharmaceutical Research
52. Predicting druggable binding sites at the protein–protein interface
    Jonathan C. Fuller, Nicholas J. Burgoyne, Richard M. Jackson · 2008 · Drug Discovery Today
53. Amorphous Drug Delivery Systems: Molecular Aspects, Design, and Performance
    Aditya Mohan Kaushal, Piyush Gupta, Arvind K. Bansal · 2004 · Critical Reviews in Therapeutic Drug Carrier Systems
54. A Data-Driven Approach to Predicting Successes and Failures of Clinical Trials
    Gayvert, Kaitlyn M., Madhukar, Neel S., Elemento, Olivier · 2016 · Cell chemical biology
55. Hit Identification and Optimization in Virtual Screening: Practical Recommendations Based on a Critical Literature Analysis
    Tian Zhu, Shuyi Cao, Pin-Chih Su, Ram Patel, Darshan Shah, Heta B. Chokshi, Richard Szukala, Michael E. Johnson, Kirk E. Hevener · 2013 · Journal of Medicinal Chemistry
56. Targeting ERK1/2 protein-serine/threonine kinases in human cancers
    Robert Jr. Roskoski · 2019 · Pharmacological Research
57. Pharmacokinetics
    Fan, Jianghong, de Lannoy, Inés A.M. · 2014 · Biochemical Pharmacology
58. Glioma Stem Cell Proliferation and Tumor Growth Are Promoted by Nitric Oxide Synthase-2
    Christine Elissa Eyler, Qiulian Wu, Kenneth Kar-Lung Yan, Jennifer MacSwords, Devin Chandler-Militello, Katherine L. Misuraca, Justin Durla Lathia, Michael T. Forrester, Jeongwu Lee, Jonathan S. Stamler et al. · 2011 · Cell
59. Revisiting the General Solubility Equation: In Silico Prediction of Aqueous Solubility Incorporating the Effect of Topographical Polar Surface Area
    Jogoth Ali, Patrick Camilleri, Marc B. Brown, Andrew J. Hutt, Stewart Brian Kirton · 2011 · Journal of Chemical Information and Modeling
60. Chemical predictive modelling to improve compound quality
    John G. Cumming, Andrew M. Davis, Sorel Mureşan, Markus Haeberlein, Hongming Chen · 2013 · Nature Reviews Drug Discovery
61. RNA Display Methods for the Discovery of Bioactive Macrocycles
    Yichao Huang, Mareike M. Wiedmann, Hiroaki Suga · 2018 · Chemical Reviews
62. Estimation of Aqueous Solubility for a Diverse Set of Organic Compounds Based on Molecular Topology
    Jarmo J. Huuskonen · 2000 · Journal of Chemical Information and Computer Sciences
63. Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases
    Daniel W. Neef, Alex M. Jaeger, Dennis J. Thiele · 2011 · Nature Reviews Drug Discovery
64. Natural Products as a Foundation for Drug Discovery
    John A. Beutler · 2009 · Current Protocols in Pharmacology
65. Selecting the right compounds for screening: does Lipinski's Rule of 5 for pharmaceuticals apply to agrochemicals?
    Colin M. Tice · 2001 · Pest Management Science
66. High-Throughput Screening in Drug Metabolism and Pharmacokinetic Support of Drug Discovery
    Ronald E. White · 2000 · The Annual Review of Pharmacology and Toxicology
67. INCB24360 (Epacadostat), a Highly Potent and Selective Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitor for Immuno-oncology
    Eddy W. Yue, Richard B. Sparks, Padmaja K Polam, Dilip Modi, Brent D. Douty, Brian R. Wayland, Brian M. Glass, Amy G. Takvorian, Joseph Glenn, Wenyu Zhu et al. · 2017 · ACS Medicinal Chemistry Letters
68. Intestinal permeability and its relevance for absorption and elimination
    Lennernäs, H. · 2007 · Xenobiotica
69. Toward in silico structure-based ADMET prediction in drug discovery
    Gautier Moroy, Virginie Y. Martiny, Philippe Vayer, Bruno O. Villoutreix, Maria A. Miteva · 2011 · Drug Discovery Today
70. Molecular Strategies for Targeting Antioxidants to Mitochondria: Therapeutic Implications
    Nadezda Apostolova, Víctor M. Víctor · 2014 · Antioxidants and Redox Signaling
71. The Solubility–Permeability Interplay and Its Implications in Formulation Design and Development for Poorly Soluble Drugs
    Arik Dahan, Jonathan M. Miller · 2012 · The AAPS Journal
72. Fueling Open‐Source Drug Discovery: 177 Small‐Molecule Leads against Tuberculosis
    Lluís Ballell, Robert H. Bates, Rob J. Young, Daniel Álvarez-Gómez, Emilio Álvarez-Ruíz, Vanessa Barroso, Delia Blanco, Benigno Crespo, Jaime Escribano, Rubén González et al. · 2013 · ChemMedChem
73. Effects of Cyclodextrins on Drug Delivery Through Biological Membranes
    Þorsteinn Loftsson, Stine B. Vogensen, Marcus Eli Brewster, Fífa Konrádsdóttir · 2007 · Journal of Pharmaceutical Sciences
74. Biopharmaceutical challenges associated with drugs with low aqueous solubility—The potential impact of lipid-based formulations
    Caitríona M. O’Driscoll, Brendan T. Griffin · 2007 · Advanced Drug Delivery Reviews
75. Anaplastic lymphoma kinase (ALK): Structure, oncogenic activation, and pharmacological inhibition
    Robert Jr. Roskoski · 2012 · Pharmacological Research
76. Synthesis of Natural Product Inspired Compound Collections
    Kamal Kumar, Herbert Waldmann · 2009 · Angewandte Chemie International Edition
77. Utility of Hydroxypropylmethylcellulose Acetate Succinate (HPMCAS) for Initiation and Maintenance of Drug Supersaturation in the GI Milieu
    William J. Curatolo, James Nightingale, Scott M. Herbig · 2009 · Pharmaceutical Research
78. Probing the Probes: Fitness Factors For Small Molecule Tools
    Paul Workman, Ian Collins · 2010 · Chemistry & Biology
79. Cell permeability beyond the rule of 5
    Pär Matsson, B.C. Doak, Björn Over, Jan O. Kihlberg · 2016 · Advanced Drug Delivery Reviews
80. Integrating Molecular Docking and Molecular Dynamics Simulations
    Lucianna Helene Santos, Rafaela Salgado Ferreira, Ernesto R. Caffarena · 2019 · Methods in molecular biology
81. Benchmarking the Reliability of QikProp. Correlation between Experimental and Predicted Values
    Leukothea Ioakimidis, Loizos Thoukydidis, Amin R. Mirza, Saira Naeem, Jóhannes Reynisson · 2007 · QSAR & Combinatorial Science
82. Prediction of ADMET Properties
    Ulf Norinder, Christel A. S. Bergström · 2006 · ChemMedChem
83. Potential of Plant Bioactive Compounds as SARS-CoV-2 Main Protease (Mpro) and Spike (S) Glycoprotein Inhibitors: A Molecular Docking Study
    Trina Ekawati Tallei, Sefren Geiner Tumilaar, Nurdjannah Jane Niode, Fatimawali Fatimawali, Billy J. Kepel, Rinaldi Idroes, Yunus Effendi, Shahenur Alam Sakib, Talha Bin Emran · 2020 · Scientifica
84. Emulsion-based encapsulation and delivery systems for polyphenols
    Wei Jie Lu, Alan L. Kelly, Song Miao · 2015 · Trends in Food Science & Technology
85. In silico toxicology for the pharmaceutical sciences☆
    Luis G. Valerio · 2009 · Toxicology and Applied Pharmacology
86. A practical view of ‘druggability’
    Thomas H. Keller, A. Pichota, Zheng Qin Yin · 2006 · Current Opinion in Chemical Biology
87. Stochastic Voyages into Uncharted Chemical Space Produce a Representative Library of All Possible Drug-Like Compounds
    Virshup, Aaron M., Contreras-García, Julia, Wipf, Peter, Yang, Weitao, Beratan, David N. · 2013 · Journal of the American Chemical Society
88. Comparison of a Miniaturized Shake-Flask Solubility Method with Automated Potentiometric Acid/Base Titrations and Calculated Solubilities
    Alexander Glomme, Joachim März, Jennifer Dressman · 2004 · Journal of Pharmaceutical Sciences
89. Blood Brain Barrier: A Challenge for Effectual Therapy of Brain Tumors
    Arijit Bhowmik, Rajni Khan, Mrinal K. Ghosh · 2015 · BioMed Research International
90. Targeting protein kinases in central nervous system disorders
    Laura K. Chico, Linda J. Van Eldik, Daniel Martin Watterson · 2009 · Nature Reviews Drug Discovery
91. Amorphous solid dispersions and nano-crystal technologies for poorly water-soluble drug delivery
    Chris Brough, Robert O. Williams · 2013 · International Journal of Pharmaceutics
92. MolAICal: a soft tool for 3D drug design of protein targets by artificial intelligence and classical algorithm
    Qifeng Bai, Shuoyan Tan, Tingyang Xu, Huanxiang Liu, Junzhou Huang, Xiaojun Yao · 2020 · Briefings in Bioinformatics
93. A small molecule designed to bind to the adenine nucleotide pocket of Hsp90 causes Her2 degradation and the growth arrest and differentiation of breast cancer cells
    Gabriela Chiosis, Merna N. Timaul, Brian S. Lucas, Pamela N. Münster, Fuzhong F. Zheng, Laura Sepp‐Lorenzino, Neal X. Rosen · 2001 · Chemistry & Biology
94. Identification of a chemical probe for NAADP by virtual screening
    Edmund Naylor, Abdelilah Arredouani, Sridhar R. Vasudevan, Alexander M. Lewis, Raman Parkesh, Akiko Mizote, Daniel Rosen, Justyn M. Thomas, Minoru Izumi, Arasu Ganesan et al. · 2009 · Nature Chemical Biology
95. NH…O, OH…O, and CH…O hydrogen bonds in protein–ligand complexes: Strong and weak interactions in molecular recognition
    Sanjay Sarkhel, Gautam Radhakrishna Desiraju · 2003 · Proteins Structure Function and Bioinformatics
96. Modulators of 14-3-3 Protein–Protein Interactions
    Loes M. Stevers, Eline Sijbesma, Maurizio Botta, Carol MacKintosh, Tomáš Obšil, Isabelle Landrieu, Ylenia Cau, Andrew John Wilson, Anna Karawajczyk, Jan Eickhoff et al. · 2017 · Journal of Medicinal Chemistry
97. Pharmaceutical profiling in drug discovery
    Edward H. Kerns · 2003 · Drug Discovery Today
98. Role of Cyclodextrins in Improving Oral Drug Delivery
    Þorsteinn Loftsson, Marcus Eli Brewster, M??r M??sson · 2004 · American Journal of Drug Delivery
99. Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains
    Duncan A. Hay, Oleg Fedorov, Sarah Martin, Dean C. Singleton, C. Tallant, Christopher D. Wells, S. Picaud, Martin Philpott, Octovia Monteiro, Catherine M. Rogers et al. · 2014 · Journal of the American Chemical Society
100. Something old, something new: revisiting natural products in antibiotic drug discovery
     Gerard D. Wright · 2014 · Canadian Journal of Microbiology